Semasize 0.5 Milligram Prefilled Syringe 0.36 Millilitre

Semasize 0.5 Milligram Prefilled Syringe 0.36 Millilitre

Prescription drug
Manufacturer / Marketer : ETABX
Expiry : 30-04-2027
AboutSemasize 0.5 Milligram Prefilled Syringe contains semaglutide, a glucagon-like peptide-1 receptor agonist prescribed for selected type 2 diabetes or weight-management treatment plans.Usage InstructionsAdminister subcutaneously once weekly on the prescribed day. Use only after receiving proper training. Rotate injection sites, dispose of the syringe safely and never share it with another person.BenefitsHelps improve blood glucose control and may support weight reduction when combined with diet, exercise and medical supervision.How it WorksSemaglutide increases glucose-dependent insulin release, lowers glucagon secretion, slows stomach emptying and reduces appetite through glucagon-like peptide-1 receptor activity.Side EffectsNausea, vomiting, diarrhoea, constipation, abdominal pain and reduced appetite are common, particularly during dose increases. Seek urgent help for severe abdominal pain, persistent vomiting, dehydration, serious allergy or vision changes.Safety AdvicePrescription and cold-chain medicine. Tell the doctor about pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, pregnancy, breastfeeding and concurrent medicines. Do not use for type 1 diabetes or diabetic ketoacidosis unless specifically directed in a specialist setting.StorageStore at 2°C to 8°C in a refrigerator. Do not freeze. Protect from light and keep in the original carton. Maintain validated cold-chain handling during delivery and follow the product leaflet for after-opening storage.
₹356.25 MRP: ₹375.00 Save ₹18.75 (5%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
AboutSemasize 0.5 Milligram Prefilled Syringe contains semaglutide, a glucagon-like peptide-1 receptor agonist prescribed for selected type 2 diabetes or weight-management treatment plans.Usage InstructionsAdminister subcutaneously once weekly on the prescribed day. Use only after receiving proper training. Rotate injection sites, dispose of the syringe safely and never share it with another person.BenefitsHelps improve blood glucose control and may support weight reduction when combined with diet, exercise and medical supervision.How it WorksSemaglutide increases glucose-dependent insulin release, lowers glucagon secretion, slows stomach emptying and reduces appetite through glucagon-like peptide-1 receptor activity.Side EffectsNausea, vomiting, diarrhoea, constipation, abdominal pain and reduced appetite are common, particularly during dose increases. Seek urgent help for severe abdominal pain, persistent vomiting, dehydration, serious allergy or vision changes.Safety AdvicePrescription and cold-chain medicine. Tell the doctor about pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, pregnancy, breastfeeding and concurrent medicines. Do not use for type 1 diabetes or diabetic ketoacidosis unless specifically directed in a specialist setting.StorageStore at 2°C to 8°C in a refrigerator. Do not freeze. Protect from light and keep in the original carton. Maintain validated cold-chain handling during delivery and follow the product leaflet for after-opening storage.

Related Products